Research and Markets: Overview of Biomarkers in Parkinson's Disease

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rl7npd/biomarkers_in) has announced the addition of the "Biomarkers in Parkinson's Disease - Overview " report to their offering.

Biomarkers have been a heavily studied topic of interest, and recently on the rise is the interest in neurodegenerative disorders, particularly Parkinson's Disease. Although there are many techniques used to track Parkinson's Disease progression, this report will primarily focus on blood-based and cerebrospinal fluid-based biomarkers currently under investigation. In addition to covering extensive background information, this report will also highlight market growth and outlook, and feature clinical trial and pipeline information.

Biomarkers in Parkinson's Disease is focused on the biomarker identification and development in patients with Parkinson's Disease. This report focuses on the Parkinson's Disease space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With regards to employing the use of biomarkers for Parkinson's Disease, Biomarkers in Parkinson's Disease captures market growth of biomarkers, advantages, disadvantages, and validation techniques.

Experts interviewed in this report include:

  • Dr. Andrew West, Associate Professor of Neurology and Neurobiology and Co-Director, Center for Neurodegeneration and Experimental Therapeutics.
  • Dr. Xuemei Huang, Professor and Vice Chair, Department of Neurology; Professor of Neurosurgery, Radiology, Pharmacology, and Kinesiology. Director; Hershey Brain Analysis Research Laboratory for Neurodegenerative Disorders, Penn State University-Milton, S. Hershey Medical Center Department of Neurology.
  • Dr. Andreas Jeromin, CSO and President of Atlantic Biomarkers.

Key Topics Covered:

Chapter 1: The Focus Of This Report

Chapter 2: Biomarkers And Their Clinical Utility

Chapter 3: Biomarkers In Neurodegenerative Disorders

Chapter 4: Parkinson's Disease

Chapter 5: Penn State Hershey Medical Center

Chapter 6: Survey Results

Chapter 7: Clinical Trials And Pipeline Information In Parkinson'S Disease

For more information visit http://www.researchandmarkets.com/research/rl7npd/biomarkers_in

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices